Đang chuẩn bị liên kết để tải về tài liệu:
High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting

High-dose (HD) chemotherapy with melphalan and autologous blood stem cell transplantation (ABSCT) for treatment of symptomatic multiple myeloma (MM) on an outpatient basis has been well established in the USA and Canada, whereas in Germany and Western Europe an inpatient setting is the current standard. |